Healthy ageing is not a race for the lowest possible “biological age”. The World Health Organization describes it through functional ability: whether people can do the things that matter to them. Measurement is therefore most useful when it helps track strength, mobility, body composition, blood pressure and change over time. No scale, dynamometer or wearable can predict one individual’s lifespan.
WHO defines healthy ageing as developing and maintaining the functional ability that enables wellbeing in older age. This includes mobility, decision-making, relationships, learning and meeting everyday needs. A person can live with a chronic condition and still age well when it is managed and does not prevent daily life.
That changes the question a measurement should answer. “Am I keeping the strength I need for everyday life?”, “Are my blood pressure or muscle-to-fat balance moving in an unfavourable direction?” and “Is this a stable pattern worth investigating?” are usually more useful than “How old is my body?”
Results should therefore be ranked by practical value, not by how futuristic they sound. Function and symptoms come before proprietary scores; repeatedly and correctly measured blood pressure carries more weight than a vascular-age estimate.
Function is the most direct signal. Changes in walking speed, difficulty rising from a chair, poorer balance, new falls or unusual fatigue during familiar activity can matter more than a small shift on a device. A rapid change is also a reason to act sooner rather than wait for another score.
Grip strength is a simple supporting measure of overall muscle function. Lower grip is associated with poorer outcomes in large populations, but that association is not a personal life-expectancy clock. Age, sex, body size, technique, hand pain and current fatigue all affect the value.
The best use is a consistent protocol alongside everyday function. A rapid decline, or weakness combined with unintentional weight loss and slower walking, deserves professional assessment rather than independent “longevity-score optimisation”.
Body composition adds structural context. In later life, the goal is not automatically the lowest body weight or body-fat percentage. Avoiding unnecessary muscle loss matters, while high fat—especially central fat—should not be overlooked. BMI alone cannot distinguish these situations.
Bioimpedance, including InBody, is an estimate based on the body’s electrical conductivity. Hydration, food, exercise and testing conditions all affect the result, so decimal places should not be treated as absolute truth. The most useful signal is a trend from the same device under similar conditions.
Pay particular attention to unintentional weight loss, a simultaneous decline in muscle and strength, or a gradual rise in central fat and blood pressure. A small isolated change in estimated fat or water without a functional change often reflects ordinary measurement variability.
Blood pressure is one of the best-established modifiable risk factors. Systolic pressure often rises with age at population level, but that does not make a high reading “normal for age”. Repeated readings with good technique and an individual review of treatment, tolerance and other conditions matter.
Physical activity, smoking, sleep, laboratory values, medical history and, when relevant, waist circumference complete the cardiometabolic picture. InBody, Max Pulse and wearables cannot replace glucose, blood lipids, kidney tests or a clinical assessment.
Short-term pulse variability and Max Pulse APG can add trend context when conditions are comparable. They are sensitive to breathing, posture, movement, sleep, caffeine, alcohol, illness and medication. PPG-derived variability is not ECG, and APG is an indirect view of peripheral pulse-wave shape—not a direct measure of arterial stiffness or lifespan.
There is no universal panel for everyone. A person without symptoms needs a different plan from someone with unintentional weight loss, high blood pressure or repeated falls. This table is a map, not a treatment plan.
| Layer | What to track | How to use it |
|---|---|---|
| Everyday function | walking, chair rise, stairs, balance, falls and fatigue | act on a new or rapid change; do not wait for another score |
| Muscle function | grip and, when appropriate, chair-rise or walking tests | use the same protocol and relate the trend to daily performance |
| Body composition | muscle, fat and unintentional weight change | compare similar conditions; do not over-read isolated decimals |
| Blood pressure | repeated resting readings and a home average | use the right cuff and technique; discuss persistent changes with a clinician |
| Supporting indices | HRV/PRV, APG or proprietary scores | context from the same method, not a diagnosis or a biological “age” |
First establish a baseline. Repeat a measurement only after enough time for a real change, and under similar conditions: time of day, meals, hydration and no hard exercise immediately beforehand. Blood pressure should be based on several readings rather than one result.
Decide in advance what would change the next step. A modest loss of weight with preserved strength means something different from the same loss alongside falling muscle and slower walking. Likewise, one lower HRV result after poor sleep does not carry the same weight as repeatedly high blood pressure.
The popularity of words such as longevity, biological age and vascular age does not change the basic rule: a useful marker has a described method, known limitations and a link to a sensible decision. If a score cannot explain what it measures or what should happen next, it is closer to a marketing signal than a health compass.
About the measurement
The main page about body composition measurement, result output and the visit.
More reading
FAQ
There is no single number that can summarise or predict healthy ageing. Everyday function, muscle strength, repeated blood pressure, body composition and ordinary preventive care are more useful together.
No. Lower grip is associated with higher risk across populations, but one reading cannot predict an individual lifespan. A comparable trend and its relationship to daily function are more useful.
Only when the method and limitations are clear. It may be used as a supporting trend from the same method, not as the body’s true age, a diagnosis or an exact risk prediction.
For routine tracking, weeks to months usually make more sense than days. A consistent protocol and enough time for real change matter more than frequent testing.
After rapid or unintentional weight loss, new functional decline, falls, repeatedly high blood pressure, new symptoms or a marked drop in strength. Acute symptoms such as chest pain, shortness of breath, paralysis or speech disturbance require urgent help.
Sources
Premium measurement combines body composition, grip strength, blood pressure and supporting vascular and stress context. Its value is not one “longevity score”, but a clear baseline and a comparable trend.